Literature DB >> 23035939

Optimizing blood pressure control in hypertension: the need to use ABPM.

Roland E Schmieder1, Marina V Lehmann, Stephanie Schmidt.   

Abstract

Hypertension is the most prevalent, treatable cause of cardiovascular (CV) disease. Patients with hypertension and one or more comorbidities increasingly form a significant part of the primary care practitioner's caseload. The emphasis on intensive blood pressure (BP) lowering has softened, encouraging any degree of BP lowering, since any fall in BP is beneficial for reducing CV risk. Consistency of BP control during long-term therapy (i.e. low visit-to-visit variability) and decreasing BP variability over 24-h may be as, if not more, important than degree of BP lowering per se. Fluctuations in BP between visits as well as within a 24-h period have been associated with increased CV risk. Ambulatory BP monitoring (ABPM) is a crucial element of the clinician's armamentarium not only for assessing the "true" BP load and fluctuations under real-life conditions but for identification of various abnormal BP patterns that may require attention, including white- coat hypertension, masked hypertension, non-dipping and the morning BP surge. ABPM provides accurate assessment of treatment effectiveness over 24-h and may lead to better tailoring of therapy. This article reviews the benefits of ABPM and discusses the importance of selecting long-acting antihypertensive agents for optimizing BP control.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23035939     DOI: 10.3109/08037051.2012.727253

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  4 in total

1.  Insights in Public Health: Ambulatory Blood Pressure Monitoring: Underuse in Clinical Practice in Hawai'i.

Authors:  Deborah Taira; Tetine Sentell; Cheryl Albright; Doug Lansidell; Kazuma Nakagawa; Todd Seto; Joel Mark Stevens
Journal:  Hawaii J Med Public Health       Date:  2017-11

2.  Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.

Authors:  Larissa Grigoryan; Valory N Pavlik; David J Hyman
Journal:  J Am Soc Hypertens       Date:  2013-07-23

3.  Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study.

Authors:  Deanna G Cheung; Diego Aizenberg; Vladimir Gorbunov; Kudsia Hafeez; Chien-Wei Chen; Jack Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-16       Impact factor: 3.738

4.  Efficacy of angiotensin receptor neprilysin inhibitor in Asian patients with refractory hypertension.

Authors:  Wanjing Li; Minghui Gong; Qin Yu; Rihui Liu; Kaiming Chen; Wei Lv; Fumei Yao; Zhaolong Xu; Yi Xu; Wei Song; Yinong Jiang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-03-07       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.